Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
For healthcare leaders, biotech innovators, and strategy folks: this signals that the value proposition for GLP-1 therapies isnt solely weight loss or glycaemic control its anti-inflammation opens new therapeutic categories, pricing/benefit models, and organisational partnerships (endocrinology + immunology, metabolism + organ disease)
GIP/GLP-1 receptor agonist Tirzepatide for type 2 diabetes and obesity
In Australia, legitimate GLP-1 medicines are prescription-only medicines and should be used under medical supervision
What Is Hypoglycaemia
US$ 28.29
US$ 23.61
US$ 28.28
